These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30445256)

  • 21. Underestimated Rate of Status Epilepticus according to the Traditional Definition of Status Epilepticus.
    Ong CT; Wong YS; Sung SF; Wu CS; Hsu YC; Su YH; Hung LC
    ScientificWorldJournal; 2015; 2015():801834. PubMed ID: 26185783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Super-Refractory Status Epilepticus in Children: A Retrospective Cohort Study.
    Vasquez A; Farias-Moeller R; Sánchez-Fernández I; Abend NS; Amengual-Gual M; Anderson A; Arya R; Brenton JN; Carpenter JL; Chapman K; Clark J; Gaillard WD; Glauser T; Goldstein JL; Goodkin HP; Guerriero RM; Lai YC; McDonough TL; Mikati MA; Morgan LA; Novotny EJ; Ostendorf AP; Payne ET; Peariso K; Piantino J; Riviello JJ; Sands TT; Sannagowdara K; Tasker RC; Tchapyjnikov D; Topjian A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Pediatr Crit Care Med; 2021 Dec; 22(12):e613-e625. PubMed ID: 34120133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with treatment delays in pediatric refractory convulsive status epilepticus.
    Sánchez Fernández I; Gaínza-Lein M; Abend NS; Anderson AE; Arya R; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Helseth AR; Jackson MC; Kapur K; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello JJ; Tasker RC; Tchapyjnikov D; Topjian AA; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2018 May; 90(19):e1692-e1701. PubMed ID: 29643084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latency to treatment of status epilepticus is associated with mortality and functional status.
    Cheng JY
    J Neurol Sci; 2016 Nov; 370():290-295. PubMed ID: 27772779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of intravenous levetiracetam as an adjunctive treatment in pediatric refractory status epilepticus.
    Kim JS; Lee JH; Ryu HW; Lim BC; Hwang H; Chae JH; Choi J; Kim KJ; Hwang YS; Kim H
    Pediatr Emerg Care; 2014 Aug; 30(8):525-8. PubMed ID: 25062293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: A multicenter, national, two-year prospective surveillance study.
    Meyer S; Langer J; Poryo M; Bay JG; Wagenpfeil S; Heinrich B; Nunold H; Strzelczyk A; Ebrahimi-Fakhari D
    Epilepsia Open; 2023 Jun; 8(2):411-424. PubMed ID: 36764666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
    McTague A; Kneen R; Kumar R; Spinty S; Appleton R
    Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart review.
    Terman SW; Slinger G; Koek A; Skvarce J; Springer MV; Ziobro JM; Burke JF; Otte WM; Thijs RD; Braun KPJ
    Epilepsia Open; 2023 Jun; 8(2):371-385. PubMed ID: 36693718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric Status Epilepticus: Treat Early and Avoid Delays.
    Morgan LA; Hrachovec JB; Goodkin HP
    Paediatr Drugs; 2023 Jul; 25(4):411-424. PubMed ID: 37178271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reponse of second-line treatment in focal status epilepticus: A tertiary hospital experience.
    Llauradó A; Campos D; Quintana M; Ballvé A; Fonseca E; Abraira L; Giffreu A; Toledo M; Santamarina E
    Epilepsy Res; 2022 Sep; 185():106988. PubMed ID: 35907324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of pediatric patients with status epilepticus lasting 5-29 min versus ≥30 min.
    Sánchez Fernández I; Vendrame M; Kapur K; Klehm J; Uysal S; Gedik M; An S; Jillella D; Zelener J; Syed S; Gooty V; Rotenberg A; Loddenkemper T
    Epilepsy Behav; 2014 Aug; 37():1-6. PubMed ID: 24949574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convulsive status epilepticus in children: etiology, treatment protocol and outcome.
    Saz EU; Karapinar B; Ozcetin M; Polat M; Tosun A; Serdaroglu G; Gokben S; Tekgul H
    Seizure; 2011 Mar; 20(2):115-8. PubMed ID: 21195636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-line medication dosing in pediatric refractory status epilepticus.
    Vasquez A; Gaínza-Lein M; Abend NS; Amengual-Gual M; Anderson A; Arya R; Brenton JN; Carpenter JL; Chapman K; Clark J; Farias-Moeller R; Gaillard WD; Glauser T; Goldstein JL; Goodkin HP; Guerriero RM; Kapur K; Lai YC; McDonough TL; Mikati MA; Morgan LA; Novotny EJ; Ostendorf AP; Payne ET; Peariso K; Piantino J; Riviello JJ; Sannagowdara K; Tasker RC; Tchapyjnikov D; Topjian A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2020 Nov; 95(19):e2683-e2696. PubMed ID: 32913024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical treatment of pediatric status epilepticus.
    Abend NS; Gutierrez-Colina AM; Dlugos DJ
    Semin Pediatr Neurol; 2010 Sep; 17(3):169-75. PubMed ID: 20727486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing in the treatment of status epilepticus: From basics to the clinic.
    Gaínza-Lein M; Fernández IS; Ulate-Campos A; Loddenkemper T; Ostendorf AP
    Seizure; 2019 May; 68():22-30. PubMed ID: 29884518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time to Treatment in Pediatric Convulsive Refractory Status Epilepticus: The Weekend Effect.
    Barcia Aguilar C; Amengual-Gual M; Sánchez Fernández I; Abend NS; Anderson A; Appavu B; Arya R; Brenton JN; Carpenter JL; Chapman KE; Clark J; Farias-Moeller R; Gaillard WD; Gaínza-Lein M; Glauser T; Goldstein JL; Goodkin HP; Guerriero RM; Huh L; Lai YC; McDonough TL; Mikati MA; Morgan LA; Novotny EJ; Ostendorf A; Payne ET; Peariso K; Piantino J; Riviello J; Sannagowdara K; Sheehan T; Sands TT; Tasker RC; Tchapyjnikov D; Topjian AA; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Pediatr Neurol; 2021 Jul; 120():71-79. PubMed ID: 34022752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parenteral Long-Acting Antiseizure Medications Are Used More Often to Treat Seizure Clusters Than Convulsive Status Epilepticus in the Pediatric Emergency Department.
    Pfeiffer CK; Mackay MT; Long E; Stephens D; Dalziel SR; Babl FE;
    J Child Neurol; 2022 Jun; 37(7):589-598. PubMed ID: 35142572
    [No Abstract]   [Full Text] [Related]  

  • 39. The need for improved management of status epilepticus in children in Australia: Time from seizure onset to treatment is consistently delayed.
    Uppal P; Cardamone M; Fonseca B; Briggs N; A Lawson J
    J Paediatr Child Health; 2022 Feb; 58(2):261-266. PubMed ID: 34397128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis.
    Brigo F; Nardone R; Tezzon F; Trinka E
    Epilepsy Behav; 2015 Aug; 49():325-36. PubMed ID: 25817929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.